Cellular and cell-derived components of adipose-derived tissue for the purposes of
dermatologic and aesthetic rejuvenation applications have become increasingly studied and …

Within the last years, the use of stem cells (embryonic, induced pluripotent stem cells, or
hematopoietic stem cells), Progenitor cells (eg, endothelial progenitor cells), and most …

Stem cell-based therapy has been suggested as a promising option for the treatment of
renal ischemia-reperfusion injury (IRI). However, how to efficiently deliver stem cells remains …

We have chosen to test the safety of human intracerebroventricular (ICV) brain injections of
autologous non-genetically-modified adipose-derived stromal vascular fraction (ADSVF). In …

Significant progress has been made to advance stem cell products as potential therapies for
kidney diseases: various kinds of stem cells can restore renal function in preclinical models …

Advanced therapy medicinal products (ATMPs) offer new prospects to improve the treatment
of conditions with unmet medical needs. Kidney diseases are a current major health concern …

Solid organ and composite tissue allotransplanation have been widely applied to treat end-
stage organ failure and massive tissue defects, respectively. Currently there are a lot of …

Background Osteoarthritis (OA) is the most common joint degenerative disorder, with little
effective therapy to date. Nanofat is a cocktail of cells obtained from fat tissue, which …

Human mesenchymal stem cells (MSCs) can be isolated from various tissues. However, the
cytokine profile in different MSC types remains unclear. In this study, MSCs were extracted …

Despite the fact that a significant fraction of kidney graft dysfunctions observed after
transplantation is due to ischemia‐reperfusion injuries, there is still no clear consensus …